Skip to content
Accessibility help

Search NICE…

Skip to content

Guidance
Standards and indicators
Clinical Knowledge Summaries (CKS)
British National Formulary (BNF)
BNF for Children (BNFC)
Life sciences
More from NICE

Search results

Skip to results

Area of interest

Area of interestAntimicrobial prescribing (40)COVID-19 (36)

Type

TypeGuidance (4949)Indicators (319)News (351)NICE advice (498)Quality standards (257)Research recommendations (1786)

Status

StatusAwaiting development (332)Discontinued (466)In consultation (11)In development (430)Published (2572)Topic prioritisation (382)

Last updated

Last updatedLast 3 months (201)Last 6 months (380)Last year (702)Last 3 years (1439)

Guidance programme

Guidance programmeAntimicrobial prescribing guidelines (27)Antimicrobial resistance guidance (2)Cancer service guidelines (10)Clinical guidelines (392)COVID-19 rapid guidelines (27)Diagnostics guidance (88)Health technology evaluations (63)HealthTech guidance (770)Highly specialised technologies guidance (48)Interventional procedures guidance (1001)Medical technologies guidance (149)Medicines practice guidelines (5)NICE guidelines (579)Public health guidelines (89)Safe staffing guidelines (7)Social care guidelines (47)Technology appraisal guidance (2306)

Advice programme

Advice programmeCOVID-19 rapid summaries (8)Evidence summaries (172)Medtech innovation briefings (324)NICE reviews (2)

Showing 2386 to 2400 of 8904 results

Sort by

Elexacaftor–tezacaftor–ivacaftor and ivacaftor for treating cystic fibrosis with at least 1 F508del mutation in the CFTR gene in children aged 2 to 5 [TSID10767]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Ceftobiprole medocaril for treating community- or hospital-acquired pneumonia in people 3 months to 17 years [TSID11819]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Aflibercept for untreated diabetic macular oedema [TSID10621]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Teduglutide for treating short bowel syndrome in babies 4 to 12 months [TSID10755]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Aflibercept for untreated retinopathy in babies born preterm TS ID 11943
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Subcutaneous nivolumab for treating advanced renal cell carcinoma after systemic treatment TSID 12008
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Budesonide–glycopyrronium–formoterol fumarate for treating severe asthma in people 12 years and over TS ID 12018
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Ferric maltol for treating iron deficiency anaemia in children and adolescents aged 1 month to 17 years TS ID 11994
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Ustekinumab for the treatment of moderately to severely active Crohn's disease in children [TS ID 11955]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Mexiletine hydrochloride for treating myotonia in children and adolescents with myotonic disorders [TS ID 11978]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Veverimer for treating metabolic acidosis in chronic kidney disease [ID3832]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Evinacumab for treating homozygous familial hypercholesterolemia in children aged 6 months to 11 [TSID11806]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Mepolizumab for treating chronic obstructive pulmonary disease with eosinophil-associated exacerbations TSID12019
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Lenacapavir for treating multidrug resistant HIV-1 [ID6196]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Letermovir for preventing cytomegalovirus infection in people under 18 years after allogeneic haematopoietic stem cell transplant [TS ID 11868]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation

Previous page
1
…
158
159
Current page 160
161
162
…
594
Page 160 of 594
Next page

Guidance
Standards and indicators
Clinical Knowledge Summaries (CKS) Clinical Knowledge Summaries
British National Formulary (BNF) British National Formulary
BNF for Children (BNFC) British National Formulary for Children
Life sciences
Library and knowledge services

What NICE does
Implementing NICE guidance
Get involved
About us
Careers
News, blogs and podcasts
Newsletters and alerts
Contact us
Leave feedback
Reusing our content
NICE UK Open Content Licence
Syndicate our content
Events

Facebook
X
YouTube
LinkedIn

Accessibility
Freedom of information
Glossary
Terms and conditions
Privacy notice
Cookies

© NICE 2026. All rights reserved. Subject to Notice of rights.